MiR-25 regulates apoptosis by targeting bim in human ovarian cancer

Oncology Reports

Volumn 27, Issue 2, 2012, Pages 594-598

  Zhang, Haiyan ^a   Zuo, Zhi ^a   Lu, Xin ^a   Wang, Li ^a   Wang, Haiyan ^a   Zhu, Zhiling ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Bim; MiR 25; Ovarian cancer

Indexed keywords

BIM PROTEIN; CASPASE 3; COMPLEMENTARY DNA; MICRORNA; MICRORNA 25; PROTEIN BAX; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RNA GENE; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 84862908319     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1530     Document Type: Article

References (26)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006. (Pubitemid 44430905)
3. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007. (Pubitemid 47187346)
4. Jovanovic M and Hengartner MO: miRNAs and apoptosis: RNAs to die for. Oncogene 25: 6176-6187, 2006. (Pubitemid 44527848)
5. Cannistra SA: Cancer of the ovary. N Engl J Med 351: 2519-2529, 2004.
6. Greenlee RT, Hill-Harmon MB, Murray T and Thun M: Cancer statistics, 2001. CA Cancer J Clin 51: 15-36, 2001. (Pubitemid 32166444)
7. Poliseno L, Salmena L, Riccardi L, et al: Identification of the miR-106b-25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29, 2010.
8. Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG and Tan TM: Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 100: 1234-1242, 2009.
9. Kan T, Sato F, Ito T, et al: The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136: 1689-1700, 2009.
10. Chen C, Ridzon D, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.
11. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
12. Jelovac D and Armstrong DK: Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin 61: 183-203, 2011.
13. Dahiya N and Morin PJ: MicroRNAs in ovarian carcinomas. Endocr Relat Cancer 17: F77-F89, 2010.
14. Spannuth WA, Sood AK and Coleman RL: Angiogenesis as a strategic target for ovarian cancer therapy. Nat Clin Pract Oncol 5: 194-204, 2008. (Pubitemid 351493679)
15. Darcy KM and Schilder RJ: Relevant molecular markers and targets. Gynecol Oncol 103: S6-S13, 2006. (Pubitemid 44740193)
16. Tan DS, Agarwal R and Kaye SB: Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 7: 925-934, 2006. (Pubitemid 44615952)
17. Nana-Sinkam SP and Croce CM: MicroRNAs as therapeutic targets in cancer. Transl Res 157: 216-225, 2011.
18. Law PT and Wong N: Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 26: 437-449, 2011.
19. Gandellini P, Profumo V, Folini M and Zaffaroni N: MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin Ther Targets 15: 265-279, 2011.
20. Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol 223: 102-115, 2011.
21. Spiliotis J, Halkia E and Roukos DH: Ovarian cancer screening and peritoneal carcinomatosis: standards, 'omics' and miRNAs for personalized management. Expert Rev Mol Diagn 11: 465-467, 2011.
22. Shih KK, Qin LX, Tanner EJ, et al: A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecol Oncol 121: 444-450, 2011.
23. Kim YK, Yu J, Han TS, et al: Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37: 1672-1681, 2009.
24. Kumar M, Lu Z, Takwi AA, et al: Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 30: 843-853, 2011.
25. O'Connor L, Strasser A, O'Reilly LA, et al: Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17: 384-395, 1998. (Pubitemid 28045479)
26. Piñon JD, Labi V, Egle A and Villunger A: Bim and Bmf in tissue homeostasis and malignant disease. Oncogene 27: S41-S52, 2008.